REQUEST A DEMO
Total
USD $0.00
Search more companies

Instituto Neurociencias De Narino Ips Sas (Colombia)

Main Activities: Ambulatory Health Care Services
Secondary Activities: Diagnostic Imaging Centers | Other Ambulatory Health Care Services
Full name: Instituto Neurociencias De Narino Ips Sas Profile Updated: February 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Instituto Neurociencias De Narino Ips Sas is a company based in Colombia, with its head office in Pasto. The enterprise operates in the Ambulatory Health Care Services industry. It was incorporated on March 12, 2018. The company’s latest financial report indicates a net sales revenue increase of 229.09% in 2025. There was a total growth of 203.33% in Instituto Neurociencias De Narino Ips Sas’s total assets over the same period. The net profit margin of Instituto Neurociencias De Narino Ips Sas decreased by 3.38% in 2025.

Headquarters
Cl 14 No.33 - 15 Con Cra 34 No. 13 - 8
Pasto; Narino;

Contact Details: Purchase the Instituto Neurociencias De Narino Ips Sas report to view the information.

Basic Information
Registered Capital:
Purchase the Instituto Neurociencias De Narino Ips Sas report to view the information.
Financial Auditors:
Purchase the Instituto Neurociencias De Narino Ips Sas report to view the information.
Incorporation Date:
March 12, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Instituto Neurociencias De Narino Ips Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
229.09%
Total Operating Revenue
229.09%
Operating Profit
197.04%
EBITDA
197.04%
Net Profit/Loss for the Period
210.4%
Total Assets
203.33%
Total Equity
236.76%
Operating Profit Margin
-6.16%
Net Profit Margin
-3.38%
Return on Equity (ROE)
-5.98%
Quick Ratio
3.68%
Cash Ratio
0.77%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?